Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for Anemia Treatment
USAMP#12465307SKU: 00069130904Retacrit®
License Required
Product Spotlight
- High-potency Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for effective anemia management.
- Single-dose 1 mL vial designed for ease of use and minimal waste.
- Manufactured by Pfizer Biosimilar, ensuring pharmaceutical quality and reliability.
- Formulated for subcutaneous or intravenous administration, providing flexibility in clinical application.
- Requires refrigeration to maintain stability and efficacy of the medication.
- Latex-free packaging to minimize allergic reactions and ensure patient safety.
- An essential hematopoietic agent for patients with chronic kidney disease, chemotherapy-induced anemia, or HIV-related anemia.
